New Oral Selective Estrogen Receptor Degraders Redefine Management of Estrogen Receptor–Positive Breast Cancer

Annual Review of Medicine · Published 2025-01-27 · DOI 10.1146/annurev-med-052423-122001

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1146/annurev-med-052423-122001

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2025

Related articles

• CD70: An Emerging Anticancer Target in Renal Cell Carcinoma and Beyond · Annual Review of Medicine · 2024 · Same journal
• Emerging Long-Term Risks of the Use of Proton Pump Inhibitors and Potassium-Competitive Acid Blockers · Annual Review of Medicine · 2024 · Same journal
• Biologic Medications for Severe Asthma: Implications for Understanding Pathogenic Heterogeneity and Endotypes · Annual Review of Medicine · 2024 · Same journal
• Lessons from the Use of Monoclonal Antibodies to SARS-CoV-2 Spike Protein During the COVID-19 Pandemic · Annual Review of Medicine · 2024 · Same journal
• Advances in Therapy for Refractory Epilepsy · Annual Review of Medicine · 2024 · Same journal
• Approach to Therapy for Chronic Pouchitis · Annual Review of Medicine · 2025 · Same journal
• Cancer Neoantigen Vaccines Emerge Efficacious · Annual Review of Medicine · 2026 · Same journal
• Lipoprotein(a): An Underappreciated Inherited Risk Factor for Atherosclerosis, Aortic Stenosis, and Abdominal Aortic Aneurysm · Annual Review of Medicine · 2025 · Same journal
• A New Era in the Medical Management of Obesity · Annual Review of Medicine · 2026 · Same journal
• Sewers to Solutions: A Guide to Wastewater Pathogen Monitoring · Annual Review of Medicine · 2025 · Same journal